Gossamer Bio Inc (NASDAQ: GOSS): Stock Forecast For 2024 Still Looks Weak With A -334.78% Decline

In the last trading session, 1.25 million shares of the Gossamer Bio Inc (NASDAQ:GOSS) were traded, and its beta was 1.74. Most recently the company’s share price was $1.15, and it changed around -$0.12 or -9.45% from the last close, which brings the market valuation of the company to $259.42M. GOSS currently trades at a discount to its 52-week high of $1.88, offering almost -63.48% off that amount. The share price’s 52-week low was $0.45, which indicates that the current value has risen by an impressive 60.87% since then. We note from Gossamer Bio Inc’s average daily trading volume that its 10-day average is 1.3 million shares, with the 3-month average coming to 1.11 million.

Gossamer Bio Inc (NASDAQ:GOSS) trade information

Instantly GOSS has showed a red trend with a performance of -9.45% at the end of last trading. The performance over the last five days has remained in the red territory. The company’s shares are currently up 26.03% year-to-date, but still down -12.21% over the last five days. On the other hand, Gossamer Bio Inc (NASDAQ:GOSS) is -16.67% down in the 30-day period. We can see from the shorts that 11.09 million shares have been sold at a short interest cover period of 6.54 day(s).

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The consensus price target as assigned by Wall Street analysts is $3.75, which translates to bulls needing to increase their stock price by 69.33% from its current value. Analyst projections state that GOSS is forecast to be at a low of $2 and a high of $5.

Gossamer Bio Inc (GOSS) estimates and forecasts

Gossamer Bio Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 38.09 percent over the past six months and at a 38.98% annual growth rate that is well above the industry average of 13.60%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 65.40% in revenue this quarter, and will report an increase of 60.00% in the next quarter.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 11.99%. Gossamer Bio Inc earnings are expected to increase by 36.87% in 2024, but the outlook is positive 5.20% per year for the next five years.

GOSS Dividends

Gossamer Bio Inc’s next quarterly earnings report is expected to be released around May 07 and May 13.

Gossamer Bio Inc (NASDAQ:GOSS)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 2.26% of Gossamer Bio Inc shares, and 93.30% of them are in the hands of institutional investors. The stock currently has a share float of 95.46%. Gossamer Bio Inc stock is held by 114 institutions, with HHLR Advisors, LTD being the largest institutional investor. By Jun 29, 2023, it held 2.21% of the shares, which is about 4.97 million shares worth $5.97 million.

Millennium Management Llc, with 1.87% or 4.21 million shares worth $5.05 million as of Jun 29, 2023, holds the second largest percentage of outstanding shares.

Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Jun 29, 2023. The former held 2.06 million shares worth $2.47 million, making up 0.91% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 1.12 million shares worth around $1.35 million, which represents about 0.50% of the total shares outstanding.